Gregory Vlacich

554 total citations
23 papers, 324 citations indexed

About

Gregory Vlacich is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Gregory Vlacich has authored 23 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Otorhinolaryngology. Recurrent topics in Gregory Vlacich's work include Lung Cancer Diagnosis and Treatment (7 papers), Head and Neck Cancer Studies (7 papers) and Lung Cancer Treatments and Mutations (4 papers). Gregory Vlacich is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Head and Neck Cancer Studies (7 papers) and Lung Cancer Treatments and Mutations (4 papers). Gregory Vlacich collaborates with scholars based in United States, Netherlands and United Kingdom. Gregory Vlacich's co-authors include Anne E. Powell, Robert J. Coffey, Yu Shyr, Anthony J. Cmelak, Roberto Díaz, Eliot T. McKinley, M. Kay Washington, H. Charles Manning, Pamela Samson and Zhenyang Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gut.

In The Last Decade

Gregory Vlacich

20 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Vlacich United States 10 152 133 89 78 64 23 324
Kie Kian Ang United States 6 163 1.1× 128 1.0× 146 1.6× 230 2.9× 94 1.5× 7 444
Bok Ai Choo Singapore 12 144 0.9× 160 1.2× 98 1.1× 43 0.6× 55 0.9× 29 364
K. M. Stenson United States 7 226 1.5× 269 2.0× 193 2.2× 374 4.8× 97 1.5× 10 582
S. Guihard France 10 100 0.7× 70 0.5× 116 1.3× 125 1.6× 66 1.0× 47 342
Phillip Beron United States 5 104 0.7× 135 1.0× 87 1.0× 204 2.6× 38 0.6× 10 298
Vidhya Karivedu United States 10 129 0.8× 71 0.5× 129 1.4× 86 1.1× 71 1.1× 35 322
Douglas Errington United Kingdom 4 82 0.5× 153 1.2× 119 1.3× 243 3.1× 62 1.0× 5 406
M.T. Truong United States 8 103 0.7× 119 0.9× 89 1.0× 197 2.5× 20 0.3× 34 311
Yusuke Azami Japan 12 229 1.5× 109 0.8× 88 1.0× 64 0.8× 15 0.2× 30 333
Nikolaus Möckelmann Germany 13 86 0.6× 196 1.5× 148 1.7× 178 2.3× 81 1.3× 32 396

Countries citing papers authored by Gregory Vlacich

Since Specialization
Citations

This map shows the geographic impact of Gregory Vlacich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Vlacich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Vlacich more than expected).

Fields of papers citing papers by Gregory Vlacich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Vlacich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Vlacich. The network helps show where Gregory Vlacich may publish in the future.

Co-authorship network of co-authors of Gregory Vlacich

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Vlacich. A scholar is included among the top collaborators of Gregory Vlacich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Vlacich. Gregory Vlacich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malhotra, Jyoti, Mona Arbab, Matthew P. Deek, et al.. (2024). Two phase 2A clinical trials to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in oligometastatic and oligoprogressive solid tumor malignancies.. Journal of Clinical Oncology. 42(16_suppl). TPS2685–TPS2685. 4 indexed citations
2.
Zhao, Stephanie, Xiaodong Zhao, Eric Laugeman, et al.. (2024). The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR). Cureus. 16(6). e62906–e62906. 1 indexed citations
3.
Samson, Pamela, et al.. (2024). Treatment-Associated Lymphopenia from Hypofractionated vs. Conventional Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). e12–e12.
4.
Samson, Pamela, Shahed N. Badiyan, Gregory Vlacich, et al.. (2023). Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S29–S30. 1 indexed citations
5.
Price, Alex, Eric Laugeman, B. Maraghechi, et al.. (2023). Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program. Clinical and Translational Radiation Oncology. 42. 100661–100661. 6 indexed citations
6.
Semenkovich, Nicholas P., Shahed N. Badiyan, Pamela Samson, et al.. (2023). Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer. npj Precision Oncology. 7(1). 100–100. 14 indexed citations
7.
Badiyan, Shahed N., et al.. (2022). Radiation-Induced Cardiovascular Toxicities. Current Treatment Options in Oncology. 23(10). 1388–1404. 7 indexed citations
8.
Samson, Pamela, Robert Chuter, Michael J. Dubec, et al.. (2021). Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 617681–617681. 24 indexed citations
9.
Vlacich, Gregory, Shahed N. Badiyan, Matthew B. Spraker, et al.. (2021). A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma. Clinical and Translational Radiation Oncology. 30. 19–25. 1 indexed citations
10.
Park, Haeseong, Tanner M. Johanns, A. Craig Lockhart, et al.. (2019). Abstract CT212: Combining pembrolizumab with locally delivered radiation therapy for the treatment of metastatic esophageal cancer. Cancer Research. 79(13_Supplement). CT212–CT212. 1 indexed citations
11.
Badiyan, Shahed N., Michael Roach, Gregory Vlacich, Clifford G. Robinson, & Jeffrey D. Bradley. (2018). The importance of quality and consistent target volume definition in the treatment of locally advanced non-small cell lung cancer. 2. 35–35.
12.
Choi, Eunyoung, Gregory Vlacich, Theresa M. Keeley, et al.. (2017). Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach. Gut. 67(9). 1595–1605. 46 indexed citations
13.
14.
Vlacich, Gregory, Pamela Samson, Stephanie M. Perkins, et al.. (2017). Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database. Cancer Medicine. 6(12). 2886–2896. 43 indexed citations
15.
Vlacich, Gregory, Daniel E. Spratt, Roberto Díaz, et al.. (2014). Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer. Radiotherapy and Oncology. 110(3). 435–440. 44 indexed citations
16.
Powell, Anne E., Gregory Vlacich, Zhenyang Zhao, et al.. (2014). Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(1). G16–G23. 47 indexed citations
17.
Vlacich, Gregory, Daniel E. Spratt, Roberto Díaz, et al.. (2012). Dose to the Inferior Constrictor Predicts Persistent Dysphagia With Definitive ChemoIMRT in Locally Advanced Head-and-Neck Cancer (LAHNC). International Journal of Radiation Oncology*Biology*Physics. 84(3). S512–S513.
18.
Vlacich, Gregory, Roberto Díaz, Steven W. Thorpe, et al.. (2012). Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy. The Oncologist. 17(5). 673–681. 16 indexed citations
19.
Vlacich, Gregory, Martijn C. Nawijn, Gene C. Webb, & Donald F. Steiner. (2010). Pim3 negatively regulates glucose-stimulated insulin secretion. Islets. 2(5). 308–317. 14 indexed citations
20.
Vlacich, Gregory, Cheryl Roe, & Gene C. Webb. (2007). Technology Insight: microarrays—research and clinical applications. Nature Clinical Practice Endocrinology & Metabolism. 3(8). 594–605. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kie Kian Ang Breakdown of academic impact, for papers by Bok Ai Choo Breakdown of academic impact, for papers by K. M. Stenson Breakdown of academic impact, for papers by S. Guihard Breakdown of academic impact, for papers by Phillip Beron Breakdown of academic impact, for papers by Vidhya Karivedu Breakdown of academic impact, for papers by Douglas Errington Breakdown of academic impact, for papers by M.T. Truong Breakdown of academic impact, for papers by Yusuke Azami Breakdown of academic impact, for papers by Nikolaus Möckelmann
Rankless by CCL
2026